Simultaneous dobutamine stress echocardiography and 99mTc-tetrofosmin three-head single-photon emission computed tomography in patients with suspected coronary artery disease

Coronary Artery Disease

Volumn 10, Issue 7, 1999, Pages 479-487

  Barletta, Giuseppe ^a,c   Gallini, Chiara ^b   Del Bene, Riccarda ^a   Costanzo, Egidio ^b   Fantini, Fabio ^a  

^a Cardiology Department   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c NONE   (Italy)

Author keywords

Dobutamine; Radionuclide imaging; Stress echocardiography

Indexed keywords

DOBUTAMINE; TETROFOSMIN TC 99M;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HEART LEFT VENTRICLE; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY;

EID: 0033407108     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199910000-00008     Document Type: Article

References (46)

1. 1 Warner MF, Pippin JJ, DiSciascio G, Paulsen WH, Arrowod JA, Tatum JL, et al. Assessment of thallium scintigraphy and echocardiography during dobutamine infusion for the detection of coronary artery disease. Cathet Cardiovasc Diagn 1993; 29:122-127.
2. 2 Elhendy A, Cornel JH, Roelandt JRCT, van Domburg RT, Nierop PR, Gelcïynse ML, et al. Relation between contractile response of akinetic segments during dobutamine stress echocardiography and myocardial ischemia assessed by simultaneous thallium-201 single-photon emission computed tomography. Am J Cardiol 1996; 77:955-959.
3. 201TI single-photon emission computed tomography. Circulation 1995; 91:2748-2752.
4. 4 Huang PJ, Ho YL, Wa CC, Chao CL, Chen MF, Chieng PU, et al. Simultaneous dobutamine stress echocardiography and thallium-201 perfusion imaging for the detection of coronary artery disease. Cardiology 1997; 88:556-562.
5. 5 Forster T, McNeill A, Salustri A, Reijs AEM, El-Said M, Roelandt JRTC, et al. Simultaneous dobutamine stress echocardiography and technetium-99m isonitrile single-photon emission computed tomography in patients with suspected coronary artery disease. J Am Coll Cardiol 1993; 21:1591-1596.
6. 99m-Tc-MIBI single-photon emission computed tomography. Circulation 1993; 87:345-354.
7. 7 Mairesse GH, Marwick TH, Vanoverschelde JJ, Baudhuin T, Wijns W, Melin JA, et al. How accurate is dobutamine stress electrocardiography for detection of coronary artery disease? Comparison with two-dimensional echocardiography and technetium-99m methoxyl isobutyl isonitrile (MIBI) perfusion scintigraphy. J Am Coll Cardiol 1994; 24:920-927.
8. 8 Senior R, Sridhara BS, Anagnostou E, Handler C, Raftery EB, Lahiri A. Synergistic value of simultaneous stress dobutamine sestamibi single-photon-emission computerized tomography and echocardiography in the detection of coronary artery disease. Am Heart J 1994; 128:713-718.
9. 9 Elhendy A, Geleïynse ML, Roelandt JRCT, van Domburg RT, Cornel JH, TenCate FJ, et al. Evaluation by quantitative 99m technetium MIBI SPECT and echocardiography of myocardial perfusion and wall motion abnormalities in patients with dobutamine-induced ST-segment elevation. Am J Cardiol 1995; 76:441-448.
10. 10 Elhendy A, Geleïynse ML, Roelandt JRCT, van Domburg RT, TenCate FJ, Cornel JH, et al. Dobutamine-induced hypoperfusion without transient wall motion abnormalities: less severe ischemia or less severe stress. J Am Coll Cardiol 1996; 27:323-329.
11. 99m-technetium sestamibi SPECT myocardial perfusion scintigraphy for predicting extent of coronary artery disease in patients with healed myocardial infarction. Am J Cardiol 1997; 79:7-12.
12. 12 Geleïynse ML, Elhendy A, van Domburg RT, Cornel JH, Rambaldi R, Salustri A, et al. Cardiac imaging for risk stratification with dobutamine-atropine stress testing in patients with chest pain. Echocardiography, perfusion scintigraphy, or both? Circulation 1997; 96:137-147.
13. 13 Elhendy A, Geleïynse ML, van Domburg RT, Bax JJ, Nierop PR, Beerens SA, et al. Comparison of dobutamine stress echocardiography and technetium-99m sestamibi single-photon emission tomography for the diagnosis of coronary artery disease in hypertensive patients with and without left ventricular hypertrophy. Eur J Nucl Med 1998; 25:69-78.
14. 14 Khattar RS, Senior R, Lahiri A. Assessment of myocardial perfusion and contractile function by inotropic stress Tc-99m sestamibi SPECT imaging and echocardiography for optimal detection of multivessel coronary artery disease. Heart 1998; 3:274-280.
15. 15 Santoro GM, Sciagrà R, Buonamici P, Consoli N, Mazzoni V, Zerauschek F, et al. Head-to-head comparison of exercise stress testing, pharmacologic stress echocardiography, and perfusion tomography as first-line examination for chest pain in patients without history of coronary artery disease. J Nucl Cardiol 1998; 5:19-27.
16. 201TL and regional myocardial blood flow. Circulation 1997; 96:2332-2338.
17. 201TI imaging and coronary angiography in a phase III multicenter trial. Circulation 1995; 91:313-319.
18. 18 Acampa W, Cuocolo A, Sullo P, Varrone A, Nicolai E, Pace L, et al. Direct comparison of technetium 99m-tetrofosmin cardiac single photon emission tomography in patients with coronary artery disease. J Nucl Cardiol 1998; 5:265-274.
19. 19 Smart SC, Sawada S, Ryan T, Segar D, Atherton L, Berkowitz K, et al. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993; 88:405-415.
20. 20 Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. for the American Society of Echocardiography. Committee on Standards. Subcommittee on Quantification of Two-Dimensional Echocardiograms. Recommendations for the quantification of left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989; 2:358-367.
21. 21 Senior R, Lahiri A. Enhanced detection of myocardial ischemia by stress dobutamine echocardiography utilizing the 'biphasic' response of wall thickening during low and high dose dobutamine infusion. J Am Coll Cardiol 1995; 26:26-32.
22. 22 Bach DS, Hepner A, Markovitz PA, Armstrong WF. Dobutamine stress echocardiography: prevalence of a nonischemic response in a low-risk population. Am Heart J 1993; 125:1257-1261.
23. 23 Elhendy A, van Domburg RT, Bax JJ, Poldermans D, Nierop PR, Kasprzak JD, et al. Optimal criteria for the diagnosis of coronary artery disease by dobutamine stress echocardiography. Am J Cardiol 1998; 82:323-329.
24. 24 Hwang WS, He ZX, Reyes GA, Cwajg E, Verani MS. Quantitative Tc-99m tetrofosmin SPECT imaging in the assessment of coronary artery disease. J Am Coll Cardiol 1998; 31:301A.
25. 99mTc-tetrofosmin, myocardial perfusion imaging agent: implication for a one day imaging protocol. J Nucl Med 1993; 34:1254-1259.
26. 26 Nesto RW, Kowalchunck GJ. The ischemic cascade: temporal response of hemodynamic, electrocardiographic and symptomatic response of ischemia. Am J Cardiol 1987; 59:23C-30C.
27. 27 Hauser AM, Vellappillil G, Ramos RG, Gordon S, Timmis GC. Sequence of mechanical, electrocardiographic and clinical effects of repeated coronary artery occlusion in human beings: echocardiographic observations during coronary angioplasty. J Am Coll Cardiol 1985; 5:193-197.
28. 28 Sawada S, Elsner G, Segar DS, O'Shaughnessy M, Khouri S, Foltz J, et al. Evaluation of pattern of perfusion and metabolism in dobutamine-responsive myocardium. J Am Coll Cardiol 1997; 29:55-61.
29. 29 Pellikka PA, Oh JK, Bailey KR, Nichols BA, Monahan KH, Tajik AJ. Dynamic intraventricular obstruction during dobutamine stress echocardiography. A new observation. Circulation 1992; 86:1429-1432.
30. 30 Krivokapich J, Huang SC, Schelbert HR. Assessment of the effects of dobutamine on myocardial blood flow and oxidative metabolism in normal human subjects using N-13 ammonia and C-11 acetate. Am J Cardiol 1993; 71:1351-1356.
31. 31 Krivokapich J, Czernin J, Schelbert HR. Dobutamine positron emission tomography: absolute quantitation of rest and dobutamine myocardial blood flow and correlation with cardiac work and percent diameter stenosis in patients with and without coronary artery disease. J Am Coll Cardiol 1996; 28:565-572.
32. 32 Di Carli M, Czernin J, Hoh CK, Gerbaudo VH, Brunken RC, Huang S-C, et al. Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. Circulation 1995; 91:1944-1951.
33. 33 Petropoulakis P, Pavlides G, Athanassopoulos G, Vassilikos V. Coronary flow velocity changes in adjacent stenotic and normal coronary arteries during incremental intravenous dobutamine stress in patients with coronary artery disease: comparison and combination with intracoronary adenosine [abstract]. Eur Heart J 1998; 19 (suppl):334.
34. 34 Sun KT, Czernin J, Krivokapich J, Lau Y-K, Böttcher M, Maurer G, et al. Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism, and wall motion in normal and dysfunctional myocardium. Circulation 1996; 94:3145-3154.
35. 35 McGillem MJ, DeBoe SF, Friedman HZ, Mancini GBJ. The effects of dopamine and dobutamine on regional function in the presence of rigid coronary stenosis and subcritical impairments of reactive hyperemia. Am Heart J 1988; 115:970-977.
36. 36 Deligonul U, Armbruster R, Hailu A. Provocation of coronary spasm by dobutamine stress echocardiography in a patient with angiographically minimal coronary artery disease. Clin Cardiol 1996; 19:755-758.
37. 37 Varga A, Forster T, Cseh E, Varga L, Csanaáy M, Picano E, et al. Coronary vasospasm as a source of false positive results during dobutamine echocardiography [abstract]. J Am Coll Cardiol 1998; 31:369A.
38. 38 Wyffels E, Wijns W, Heyndrickx GR, de Bruyne B. Does high-dose dobutamine induce a "paradoxical" coronary vasoconstriction of atherosclerotic coronary arteries? [abstract]. Eur Heart J 1998; 19 (suppl):334.
39. 39 Meyer SL, Curry GC, Donsky MS, Twieg DB, Parkey RW, Willerson JT. Influence of dobutamine on hemodynamics and coronary blood flow in patients with and without coronary artery disease. Am J Cardiol 1976; 38:103-108.
40. 40 Warltier DC, Zyvoloski M, Gross GJ, Hardman HF, Brooks HL. Redistribution of myocardial blood flow distal to a dynamic coronary arterial stenosis by sympathomimetic amines. Comparison of dopamine, dobutamine and isoproterenol. Am J Cardiol 1981; 48:269-279.
41. 99mTc sestamibi uptake, and systolic wall thickening in the presence of coronary artery stenosis: implications for dobutamine stress testing. Circulation 1997; 7:2353-2360.
42. 42 McNeill AJ, Fioretti PM, El-Said ME, Salustri A, Forster T, Roelandt JRTC. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol 1992; 70:41-46.
43. 43 Pingitore A, Picano E, Quarta Colosso M, Reisenhofer B, Gigli G, Lucarini AR, et al. The atropine factor in pharmacologic stress echocardiography. J Am Coll Cardiol 1996; 27:1164-1170.
44. 44 Ling LH, Pellikka PA, Mahoney DW, Oh JK, McCully RB, Roger VL, et al. Atropine augmentation in dobutamine stress echocardiography: Role and incremental value in a clinical practice setting. J Am Coll Cardiol 1996; 28:551-557.
45. 45 Weissman NJ, Nidorf SM, Guerrero JL, Weyman AE, Picard MH. Optimal stage duration in dobutamine stress echocardiography. J Am Coll Cardiol 1995; 25:605-609.
46. 46 Salustri A, Fioretti PM, Pozzoli MMA, McNeill AJ, Roeland JRTC. Dobutamine stress echocardiography: its role in the diagnosis of coronary artery disease. Eur Heart J 1992; 53:1250-1254.